Indivior Pharmaceuticals (INDV) Other Operating Expenses (2023 - 2025)
Historic Other Operating Expenses for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q1 2025 value amounting to -$1.0 million.
- Indivior Pharmaceuticals' Other Operating Expenses changed N/A to -$1.0 million in Q1 2025 from the same period last year, while for Jun 2025 it was -$36.0 million, marking a year-over-year increase of 7662.34%. This contributed to the annual value of -$195.0 million for FY2024, which is 1841.0% up from last year.
- Per Indivior Pharmaceuticals' latest filing, its Other Operating Expenses stood at -$1.0 million for Q1 2025.
- Indivior Pharmaceuticals' Other Operating Expenses' 5-year high stood at $6.0 million during Q4 2023, with a 5-year trough of -$160.0 million in Q2 2024.
- In the last 3 years, Indivior Pharmaceuticals' Other Operating Expenses had a median value of -$1.0 million in 2025 and averaged -$38.0 million.
- The largest annual percentage gain for Indivior Pharmaceuticals' Other Operating Expenses in the last 5 years was 8333.33% (2024), contrasted with its biggest fall of 8333.33% (2024).
- Over the past 3 years, Indivior Pharmaceuticals' Other Operating Expenses (Quarter) stood at $6.0 million in 2023, then plummeted by 83.33% to $1.0 million in 2024, then tumbled by 200.0% to -$1.0 million in 2025.
- Its Other Operating Expenses was -$1.0 million in Q1 2025, compared to $1.0 million in Q4 2024 and -$36.0 million in Q3 2024.